|
Laxman Pai, Opalesque Asia: Andera Life Sciences, the business line specializing in innovative therapeutics and medical technologies Venture capitalist Andera Partners, has raised €456m ($443m) for its biggest-ever life sciences fund.
According to a press release from the player in private company investments in France and internationally, the sixth generation of BioDiscovery funds (BioDiscovery 6 fund) is consolidating Andera Partners' position as one of the leading players in life sciences venture capital in Europe.
Existing institutional investors include funds of funds, insurance companies, pension funds, family offices, private investors, and pharmaceutical companies, it said.
The Andera Life Sciences partners (Sofia Ioannidou, Olivier Litzka, Gilles Nobecourt, Jan Van den Bossche, Raphael Wisniewski) said: "We are honored by the support of our investors which is strengthening our position as one of the main players in our sector. The acceleration of our funds' development demonstrates investors' growing interest in financing medical innovation. For over twenty years, Andera Life Sciences' support for companies has resulted in over twenty treatments being made available to patients and their doctors. This is the work that we wish to continue."
"The new fund will enable the management team to pursue its investment strategy focused on building a balanced portfolio of innovative companies developing therapeutics and medical technologies, at all stages of...................... To view our full article Click here
|
RSS
